Диссертация (1140388), страница 19
Текст из файла (страница 19)
39–44.48.Фриденштейн, А. Я. Клеточные основы кроветворного микроокружения:125учебноепособие/А. Я. Фриденштейн, Е. А. Лурия.–Москва:Медицина, 1980. – 215 с.49. Черешнев, В.А. Экспериментальные модели в патологии: учебное пособие /В.А. Черешнев, Ю.И. Шилов, М.В. Черешнева, Е.И. Самоделкин, Т.В.Гаврилова, Е.Ю. Гусев, И.Л. Гуляева. – Пермь: ПГНИУ, 2014. – 324 с.50.Чернух, А.М. Нервная трофика в физиологии и патологии: учебное пособие /А.М. Чернух, Д.Ф. Плецитый. – Москва: Медицина, 1970.
– 258 с.51.Чертков, И.Л. Нормальное кроветворение: стволовая кроветворная клетка /И.Л. Чертков // Гематология и трансфузология. – 1993. — № 4. – С. 3-4.52.Юрина, H.A. Функциональная гетерогенность и взаимодействия клетоксоединительной ткани: учебное пособие / H.A. Юрина, А.И. Радостина. –Москва: Изд.РУДН, 1990. - 226 с.53.Юркин, А.К. Особенности катетер-ассоциированных инфекций у больныхзлокачественными лимфомами [Электронное издание] / А.К. Юркин, А.В.Шеголев, А.В. Новицкий, В.В. Тыренко, Д.А.
Горностаев // Российскийбиомедидинскийжурнал–2011.–Т.12.–Режимдоступа:http://www.medline.ru/public/pdf/12_049.pdf.54.A guide to assessing damage response pathways of the hair follicle: lessons fromcyclophosphamide-induced alopecia in mice / S. Hendrix, B. Handjiski, E.M.Peters, R. Paus // J.
Invest. Dermatol. – 2005. – V. 125. – P. 42-51.55.All catheter-related candidemia is not the same: assessment of the balance betweenthe risks and benefits of removal of vascular catheters / T. Walsh, et al. // Clin.Infect. Dis. – 2002. – V. 34. – P. 600–602.56.Antibiotic and chemotherapy / R. Finch, D. Greenwood, R. Norrby, R. Whitley,editors // – Philadelphia: Churchill Livingstone. – 2003. – 8th ed.
– P. 588-594.57.Antimicrobial peptides: general overview and clinical implications in human healthand disease / E. Guaní-Guerra, et al. // Clin. Immunol. – 2010. – V. 135. – P. 111.58.Antimicrobial peptides: the LPS connection / A. Giuliani et al. // Methods Mol.126Biol. – 2010. – V. 618. – P. 137-154.59.Bacterial Signaling / Krämer R., Jung K., editors. // WILEY-VCH Verlag GmbH& Co.
KGaA. – Weinheim, Germany. – 2010. – P. 357-375.60.Bacterial surface layer protects against antimicrobial peptides / C. De la FuenteNúñez, J. Mertens, J. Smit // Appl. Environ. Microbiol. – 2012. – 78. – P. 5452–5456.61.Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion tocatheters / M.B.C. Fontana, et al. // Curr. Microbiol. – 2006. – V. 52. – № 5. – P.350–3.62.Bacteriocins: ecology and evolution / O.
Gillor, M.A. Riley, M. Chavan, editors //Springer. – Berlin. – 2007. – P. 135-146.63.Baumann, F. Cyclophosphamide and related anticancer drugs / F. Baumann, R.J.Preiss // J. Chromatogr. B. – 2001. – 764. – P. 173–192.64.Beekman S., Henderson D. Infections caused by percutaneous intravasculardevices // Principles and practice of infectious diseases. 6th ed. / Mandell C.,Bennett J., Dolin R. - Philadelphia: Churchill Livingstone.
– 2005. - P. 3347-3361.65.Biofilms in chronic wounds / G.A. James, E. Swogger, R. Wolcott, et al. // WoundRepair Regen. – 2008. – V. 16, №1. – P. 37-44.66.Biosynthesis of bacteriocins in lactic acid bacteria / I.F. Nes, D.B. Diep, L.S.Havarstein, M.B. Brurberg , V. Eijsink, H. Holo // Antonie Van Leeuwenhoek. –1996. – V. 70. – P. 113–128.67.Boman, H. G.
Peptide antibiotics and their role in innate immunity / H. G. Boman// Annu Rev Immunol. – 1995. – №13. – P. 61-92.68.Boman, H.G. Peptide antibiotic: Holy or heretic grails of innate immunity? / H.G.Boman // Scand. J. Immunol. – 1996. – V. 43. – P. 475-482.69.Bouza, E. European perspective on intravascular catheter-related infections: reporton the microbiologyworkload, aetiology and antimicrobial susceptibility (ESGNI005 Study) / E. Bouza, R.
San Juan, P. A. Munoz // Clin. Microbiol. Infect. – 2004.– Vol. 10. – P. 838-842.12770.Breithaupt, H. The new antibiotics / H. Breithaupt // Nat Biotechnol. –1999. –№17. – P. 1165-9.71.Breukink E. The lantibiotic nisin, a special case or not? / E. Breukink , B.de Kruijff // Biochim Biophys Acta.
– 1999. – V. 1462. – P. 223–234.72.Bryers, James D. Medical biofilms / James D. Bryers // Biotechnol. Bioeng. –2008. – V. 100. – P. 1-18.73.Cano, M. Application of scanning electron microscopy and X-ray analysis tourinary tract cancer in animals and humans / M. Cano, T. Suzuki, S.M. Cohen// Scanning Microsc.
– 1993. – V. 7. – P. 363–370.74.Carper,H.Teicoplanin,vancomycin,rifampicin: in-vivoand in-vitro studieswith Staphylococcus aureus / H. T. Carper, G. W. Sullivan, and G. L. Mandell // J.Antimicrob. Chemother. – 1987. - V. 19. – P. 659-662.75.Cassat, J.E. Investigation of biofilm formation in clinical isolates ofStaphylococcus aureus/ J.E. Cassat, C.Y. Lee, M.S. Smeltzer // Methods Mol.Biol. – 2007.
– V. 391. – P. 127–144.76.Cavalier-Smith, T. The phagotrophic origin of eukaryotes and phylogeneticclassification of Protozoa / T. Cavalier-Smith // Int. J. Syst. Evol. Microbiol. –2002. – V. 52. – P. 297-354.77.CD34: structure, biology, and clinical utility / D.S. Krause, M.J. Fackler, C.I.Civin, W.S.May // Blood.
– 1996. –V. 87, №1. – P. 1-13.78.Cell–cell communication in food related bacteria / M. Gobbetti, M. De Angelis, R.Di Cagno, F. Minervini, A. Limitone // Int. J. Food Microbiol. – 2007. – V. 120. –P. 34-45.79.Central-venous catheters / Seifert H., Jansen B., Farr B.M., editors // Catheterrelated infections. 2nd ed. – New York: Marcel Dekker. – 2004. – P.
293-315.80.Cereulide synthesis in emetic Bacillus cereus is controlled by the transition stateregularAbrB,butnot by the virulenceregulator PIcR/G.Lücking,M.K. Dommel, S. Scherer, A. Fouet, M. Ehling-Schulz // Microbiology. – 2009. –V. 155, Pt. 3. – P. 922-931.12881.Cereulide synthetase gene cluster from emetic Bacillus cereus: structure andlocation on a mega virulence plasmid related to Bacillus anthracis toxin plasmidpXO1 [электронный ресурс] / M. Ehling-Schulz, M.
Fricker, H. Grallert, P.Rieck, M. Wagner, S. Scherer // BMC Microbiol. – 2006. – V. 6. – режимдоступа к статье: http://www.biomedcentral.com/1471-2180/6/20.82.Cerium, chitosan and hamamelitannin as novel biofilm inhibitors? / L. Cobrado,M.M. Azevedo, A. Silva-Dias, et al. // J Antimicrob Chemother. – 2012. – V. 67. –P. 1159-1162.83.Chao L., Levin. Structured habitats and the evolution of anti-competitor toxins inbacteria / Levin L. Chao // BR. PNAS. – 1981.
– V. 78. – P. 6324–6328.84.Characterization of pECL18 and pKPN2: a proposed pathway for the evolution oftwo plasmids that carry identical genes for a Type II restriction-modificationsystem / M.V. Zakharova, I.V. Beletskaya, Denjmukhametov, et al. // Mol. Genet.Genomics. – 2002. – V. 267. – P. 171-178.85.Characterizationoftheimportanceofpolysaccharideintercellularadhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis ofbiomaterial-based infection in a mouse foreign body infection model / M.E.Rupp, J.S.
Ulphani, P.D. Fey, et al. // Infect Immun. – 1999. – V. 67. – P. 26272632.86.Cheigh, C.I. Nisin biosynthesis and its properties / C.I. Cheigh, Y.R.Pyun //Biotechnol Lett. – 2005. – V. 27. – P. 1641–1648.87.Class IIa bacteriocins: biosynthesis, structure and activity / S. Ennahar, T.Sashihara, K. Sonomoto, A.
Ishizaki // FEMS Microbiol ReV. – 2000. – V. 24. –P. 85-106.88.Co-ordinated bacteriocin production and competence development: a possiblemechanism for taking up DNA from neighbouring species / J. Kreth, J. Merritt, W.Shi, F. Qi // Mol. Microbiol. – 2005. – V. 57. – P. 392-404. 13689.Collin, G. Decreasing catheter colonization through the use of an anticepticimpregnated catheter / G. Collin // Chest. – 1999. – Vol. 115. – P. 1632-1640.12990.Costerton, J.W. Bacterial biofilms: a common cause of persistent infections / J.W.Costerton, P.
S. Stewart, E.P. Greenberg // Science. – 1999. – V. 284. – P. 13181322.91.Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterialsurfaces / F. Costa, et al. // Acta Biomater. – 2011. – V. 7. – № 4. – P. 1431–40.92.Crnich, C. The promise of novel technology for the prevention of intravasculardevice-related bloodstream infection. II. Long-term devices / C. Crnich, D. Maki //Clin. Infect. Dis. – 2002. – Vol. 34. – P.
1362-1368.93.Crnich, C. The promise of novel technology for the prevention of intravasculardevice-related bloodstream infection. I. Pathogenesis and short-term devices / C.Crnich, D. Maki // Clin. Infect. Dis. – 2002. – Vol. 34. – P. 1232-1242.94.Cyclophosphamidemetabolism,livertoxicity,andmortalityfollowinghematopoietic stem cell transplantation / G.B.
McDonald, J.T. Slattery, M.E.Bouvier, S. Ren, A.L. Batchelder, T.F. Kalhorn, et al. // Blood. – 2003. – V. 101. –P. 2043–2048.95.Darouiche, R. Anti-infective efficacy of silver-coated medical prostheses / R.Darouiche // Clin. Infect. Dis. – 1999. – Vol. 29. – P. 1371-1377.96.Diagnosis of catheter-related infections / F. Blot et al. // Catheter-relatedinfections. 2nd ed. New York, Marcel Dekker. – 2004. – P. 37-72.97.Dobson, A.E. Identification of an operon and inducing peptide involved in theproduction of lactacin B by Lactobacillus acidophilus / A.E. Dobson, R.B.Sanozky-Dawes, T.R.
Klaenhammer // J. Appl. Microbiol. – 2007. – V. 103. – P.1766-1778.98.Donlan, Rodney M. Biofilms: Survival Mechanisms of Clinically RelevantMicroorganisms / Rodney M. Donlan and J. William Costerton// ClinicalMicrobiology Reviews. – 2002 Apr. – V. 15, No. 2. – P. 167-193.99.Durrett, R. Allelopathy in spatially distributed populations / R.
Durrett, S. Levin //J. Theor. Biol. – 1997. – V. 185. – P. 165-171.130100. Elliott, T. Prevention of CVC-related infection / T. Elliott, S. Tebbs // J. HosP.Infect. – 1998. – V. 40. - P. 193-201.101. Elliott, T. Role of antimicrobial central venous catheters for the prevention'ofassociated infections / T. Elliott // J. Antimicrob.
Chemother. – 1999. – V. 43. – P.441-446.102. Endothelial cells in physiology and in the pathophysiology of vascular disorders /D. B. Cines et al. // Blood 91. – 1998. – P. 3527–61.103. Evaluation of lacticin 3147 and a teat seal containing bacteriocin for theinhibition of mastitis pathogens / M.P. Ryan, W.J. Meaney, R.P.
Ross, C. Hill// Appl. Environ. Microbiol. – 1998. – V. 64. – P. 2287-2290.104. Evolutionary theory of bacterial quorum sensing: when is a signal not a signal? /S.P. Diggle, A. Gardner, S.A. West and A.S. Griffin // Phil. Trans. R. Soc. B. –Biological Sciences. – 2007. – V. 362. – P. 1241-1249.105.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
